Eli Lilly (LLY) PT Raised to $1,020 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,179.27 +0.83%
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Join SI Premium – FREE
Jefferies analyst Akash Tewari raised the price target on Eli Lilly (NYSE: LLY) to $1,020.00 (from $996.00) while maintaining a Buy rating.
You May Also Be Interested In
- Lilly's Taltz and Zepbound combo shows broader biomarker changes
- Helen of Troy (HELE) PT Raised to $29 at UBS on Q2 Beat
- Zeta Global Holdings Corp (ZETA) PT Raised to $38 at KeyBanc
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
